tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Xinhua Pharmaceutical Gains Approval for Marketing License Transfer
Company AnnouncementsXinhua Pharmaceutical Gains Approval for Marketing License Transfer
26d ago
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Arginine
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Arginine
26d ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Ivabradine Hydrochloride Tablets
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Ivabradine Hydrochloride Tablets
26d ago
Xinhua Pharmaceutical Secures Approval for Cobamamide Capsules License Transfer
PremiumCompany Announcements
Xinhua Pharmaceutical Secures Approval for Cobamamide Capsules License Transfer
29d ago
Shandong Xinhua Completes First Patient Enrollment for Phase II Alzheimer’s Drug Trial
PremiumCompany Announcements
Shandong Xinhua Completes First Patient Enrollment for Phase II Alzheimer’s Drug Trial
1M ago
Shandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
1M ago
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
1M ago
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure Drug
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure Drug
2M ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Icosapent Ethyl
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Icosapent Ethyl
2M ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Isavuconazonium Sulfate
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Isavuconazonium Sulfate
2M ago
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Suspension Drops
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Suspension Drops
2M ago
Shandong Xinhua Pharmaceutical Gains Approval for Icosapent Ethyl
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Icosapent Ethyl
2M ago
Shandong Xinhua Pharmaceutical Announces 2025 AGM with Key Resolutions
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Announces 2025 AGM with Key Resolutions
2M ago
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
3M ago
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
3M ago
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval
3M ago
Xinhua Pharmaceutical Gains Approval for Marketing License Change
PremiumCompany Announcements
Xinhua Pharmaceutical Gains Approval for Marketing License Change
3M ago
Shandong Xinhua Pharmaceutical Secures Approval for Pregabalin Oral Solution
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Secures Approval for Pregabalin Oral Solution
3M ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Memantine Solution
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Memantine Solution
3M ago
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review Q1 2025 Results
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Schedules Board Meeting to Review Q1 2025 Results
3M ago
Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation
Premium
Company Announcements
Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation
3M ago
Shandong Xinhua Pharmaceutical Gains Approval for Eszolam Tablets License Transfer
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Eszolam Tablets License Transfer
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >